| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | QE1Q24M65Y |
| InChI Key | SHKXZIQNFMOPBS-OOMQYRRCSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C44H79NO5 |
| Molecular Weight | 702.12 |
| AlogP | 10.61 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 4.0 |
| Number of Rotational Bond | 23.0 |
| Polar Surface Area | 106.86 |
| Molecular species | ACID |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 50.0 |
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Fatty Liver; Liver Diseases; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease | Phase 2 | ClinicalTrials |
| Fatty Liver; Lipodystrophy; Liver Diseases; Non-alcoholic Fatty Liver Disease | Phase 2 | ClinicalTrials |
| Malnutrition | Phase 1 | ClinicalTrials |
| Fatty Liver | Phase 2/Phase 3 | ClinicalTrials |
| Cholecystolithiasis; Cholelithiasis; Gallstones | Phase 2 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 246529-22-6 |
| ChEMBL | CHEMBL4297262 |
| DrugBank | DB11860 |
| EPA CompTox | DTXSID90179395 |
| FDA SRS | QE1Q24M65Y |
| PubChem | 18738120 |
| SureChEMBL | SCHEMBL548961 |